ASM International NV (ASMXF)
NEUTRALFondamental
61
Prix
$828.20
Capitalisation boursière
$40.88B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
ASM International makes the specialized machines that deposit ultra-thin layers of material onto silicon wafers, one atomic layer at a time — a step semiconductor manufacturers need to build the smallest, most advanced chips. Its core technology is atomic layer deposition (ALD), where it holds a leading market share, alongside epitaxy tools used for advanced logic and memory chips. Customers are the world's largest chipmakers building next-generation processors, including the leading-edge nodes used for AI chips.
Comment l'entreprise gagne de l'argent
ASM sells deposition equipment as capital goods: a customer buys or upgrades a tool as part of a new fab or process node, then keeps buying spare parts and service for years afterward. Because chipmakers only invest in new nodes when they expect strong demand, ASM's order book swings with the broader semiconductor capital-spending cycle. In 2025, demand for the newest 2-nanometer logic technology drove a record year, while memory-chip customers bought less than usual.
Chiffre d'affaires par segment
Deposition equipment sold to makers of logic and foundry chips, including customers building the most advanced 2-nanometer process nodes.
Equipment sold to memory-chip manufacturers, including tools for high-bandwidth DRAM; sales here fell back in 2025 after unusually strong 2024 demand from China.
Avantage concurrentiel
Brevets et licences · ÉtroitASM holds a leading share, reported above 55% in the markets it competes in, of atomic layer deposition — a process step increasingly required as chipmakers shrink transistors further. That lead rests on patented process know-how built over decades rather than on customer switching costs, and rival equipment makers are investing to close the gap as ALD becomes more central to chipmaking.
Ce qui stimule la demande
CycliqueOrders depend on how much the handful of major chipmakers plan to spend on new factories and process nodes, a decision driven by their own demand forecasts for chips — famously volatile in itself. A wave of AI-driven investment in advanced nodes can be followed by a pause once that capacity is built, as ASM's swing between strong logic demand and weak memory demand in 2025 illustrates.
Les arguments en faveur
Buyers argue that ASM's leadership in atomic layer deposition positions it to capture a growing share of each new chip factory's equipment budget as transistors keep shrinking, and that 2025's record revenue shows this demand is already materializing around advanced AI chip production.
Les arguments contre
Sellers fear that ASM's revenue is tied to a small number of customers' capital-spending decisions, that memory-chip orders can swing sharply from one year to the next as 2025 showed, and that competitors are investing to erode its lead in deposition technology.
Written by the editors, published on 18 août 2026
Direct competitors
Who this company fights with for the same customers
Generated on 23 août 2026 with claude-opus-5 — shared with all users
The world's largest wafer-processing equipment maker sells competing ALD, CVD and epitaxy deposition tools to the same logic and memory chipmakers ASM serves.
Lam's deposition line, built on the Novellus business, bids for the same CVD and ALD process steps in advanced logic and 3D NAND fabs.
Tokyo Electron competes head-on in single-wafer and batch ALD and in thermal processing furnaces, and is investing to take share in the ALD steps where ASM leads.
Kokusai is the leader in batch ALD and vertical furnaces, the exact segment where ASM's furnace and batch deposition tools compete, above all at memory makers.
The Korean toolmaker supplies ALD and PECVD deposition equipment qualified at Samsung and SK Hynix, competing with ASM for the same Korean memory budgets.
Jusung specializes in ALD deposition tools sold to Korean DRAM makers, taking on ASM in the specific ALD steps of memory production.
Bilan & Liquidités
Chiffre d'affaires
$3.34B
12 derniers mois jusqu'au dernier trimestre publié — estimation à partir de ratios par action
Résultat net
$1.07B
12 derniers mois jusqu'au dernier trimestre publié — estimation à partir de ratios par action
Flux de trésorerie libre
$235M
Capitaux propres totaux
$4.45B
Passif total
$71M
Ratio de liquidité général
2.17
Couverture des intérêts
-
Dette/EBITDA
0.06
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$713.28
Prix actuel
$828.20
Marge de sécurité
-16.1%
Fourchette de juste valeur
$463.63 - $962.92
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
37.61
ROE
26.8%
Ratio P/B
10.04
P/FCF
173.75
Marge brute
51.8%
ROIC
18.9%
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
18.9%
WACC
17.1%
ROIC − WACC
+1.8 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Critères d'analyse fondamentale
Réussi (14)
- Price CAGR 33.67%
- ROIC 18.9%
- Gross Margin 51.8%
- Debt/Equity ratio
- Operating Margin 35.4%
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 19.2%
- Revenue Growth 5Y 19.0%
- Analyst Consensus 80% Buy
- Earnings Surprise avg 17.2%
- PEG Ratio 1.98
- Earnings Quality (OCF/NI) 1.36
Échoué (7)
- P/FCF 173.75
- P/B Ratio 10.04
- CapEx intensity
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 22.8% vs 23.4%
- Piotroski F-Score 2/9
Indisponible (6)
- EPS data insufficient
- Dividend Payout NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Share Dilution (missing shares data)
Score F de Piotroski
Préoccupations financières sérieuses
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Dr. Hichem M'Saad | CEO & Chairman of the Management Board | 60 |
| Mr. Paulus Antonius Henricus Verhagen | CFO & Member of Management Board | 59 |
| Mr. Hakan Erdemir | Senior Vice President of Global Operations | 57 |
| Mr. Victor Bareño | Director of Investor Relations | - |
| Mr. Srini Vedula | Senior Vice President of Global Sales | 53 |
| Ms. Edyta Jakubek | Senior VP of Global People & Chief People Officer | 51 |
| Gary Ding | Chief Product Officer | 63 |
| Paul Ma | Corporate VP, Head of Strategy and M&A | 49 |
Risque d'audit
1
Risque du conseil
1
Risque de rémunération
2
Risque droits des actionnaires
6
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for ASMXF, sourced from Markets Gazette.